UN DPI/NGO CONFERENCE “DRUG INJECTION & HIV/AIDS: WHAT NEEDS TO BE DONE TO REACH GOAL 6?”

Slides:



Advertisements
Similar presentations
Supporting community action on AIDS in developing countries Supporting community action on AIDS in India Children Affected By AIDS in Low and Concentrated.
Advertisements

Accountable governance Danielle Morley Freshwater Action Network.
HEPATITIS C TREATMENT & INJECTING DRUG USE Annie Madden Executive Officer Australian Injecting & Illicit Drug Users League (AIVL) On a tightrope without.
Robin Pollard Operations Coordinator Youth RISE.
Robin Pollard Operations Coordinator Youth RISE.
PRESENTATION Youth and Health-an overview from the European Youth Forum Laura Cottey Member of European Youth Forum Working Group on employment and social.
Greater Involvement of People Living with HIV (GIPA)
Key Populations 18 September 2013 Béchir N’Daw, Conseiller régional en Droits de l’Homme et aux Lois, PNUD.
Susan Timberlake Senior Human Rights and Law Adviser
Giving us a global voice Cecilia Chung, USA On behalf of the Key Populations Living with HIV Advisory Group of GNP+
Key Populations: Making Them Matter in the Global HIV Response Inextricable Links: HIV and Human Rights Kevin Osborne, LINKAGES Project Director 2 March.
Beyond 2008: A global NGO review of the United Nations General Assembly Special Session on Illicit Drugs (UNGASS) AND As it may.
Strategies for MIWA. UN Women’s approach to MIWA and NSPs Empowering women and guaranteeing their rights so that they can protect themselves from infection,
Testing for key populations – from the perspectives of those living with HIV Ed Ngoksin Global Network of People Living with HIV (GNP+)
“Writing our own narratives” The Global Advocacy Agenda for Young People Living with HIV.
The perspective of a person with hepatitis C on new treatments and treatment as prevention Jack Wallace, Research Fellow. Australian Research Centre in.
Bond.org.uk The Bond Effectiveness Programme: developing a sector wide framework for assessing and demonstrating effectiveness July 2011.
AIDS 2010 Societies Tackling AIDS through Rights Presented by Christy Abraham International Theme Manager HIV & AIDS ActionAid International.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Gender and AIDS UNDP Focal Points Meeting June 2007.
Community-based approaches to tackling Global Health Challenges Mike Podmore.
FIFTH ANNIVERSARY OF THE INTERNATIONAL CONVENTION ON PERSONS WITH DISABILITIES, Madrid, 6/7 th May, 2013 Participation of children with disabilities, Gerison.
VALERIE L. LEVY INTERNATIONAL FEDERATION ON AGEING USA Office (212) mobile ( )
Washington D.C., USA, July 2012www.aids2012.org Non-positive allies & health providers promoting GIPA/MIPA in marginalized PHA communities: Experiences.
Guidance for AONB Partnership Members Welsh Member Training January 26/
Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.
Learning journey Part 1: Welcome and introduction Part 2: Concepts, evidence, and good practice: Addressing gender-based violence and engaging men and.
HIV Prevention and Treatment for Men who have sex with Men: Achievements and Challenges Ifeanyi Kelly Orazulike National Coordinator Sexual Minorities.
Follow up to the Second Independent Evaluation: UNAIDS Vision and Mission.
Speaking for Myself 2009 Child Participation Call – Investing in People.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Mary Guinn Delaney UNESCO HIV and AIDS Advisor for LAC 1st Meeting of Ministers of Health and Education to Stop HIV in Latin.
‘ There is an increasing recognition that public health often provides and added and compelling justification for safeguarding human rights, despite the.
 Since 1946 Zonta has partnered with the United Nations to improve the Status of Women  Zontians have donated to projects benefiting more than 2 million.
Operational Plan for UNAIDS Action Framework: Addressing Women, Girls, Gender Equality and HIV February 3, 2010.
UPR Thailand 2011 – HIV Affected Women and Girls NASHIDA SATTAR POLICY AND PROGRAMME SPECIALIST HIV, HEALTH AND GENDER EQUALITY UNDP, BANGKOK REGIONAL.
HIV and Human Rights: Strengthening HIV Responses Among Those Most Vulnerable Asia and Pacific Regional Consultation on Universal Access to HIV Prevention,
Stigma & Discrimination: The Undoing of Universal Access?? Dr Mandeep Dhaliwal International HIV/AIDS Alliance Lawyers Collective HIV/AIDS Unit PARA 55.
Washington D.C., USA, July 2012www.aids2012.org Treatment Monitoring & Advocacy Project: “Missing the Target Report Series” Othoman Mellouk ITPC-NA/ALCS.
UNICEF Child Friendly City Framework: a rights based local planning approach Dave Pugh CEO St Luke’s Anglicare.
The Alliance of Youth CEOs’ work on HIV and Young People Annual Meeting of the IATT on HIV and Young People 15 – 17 APRIL 2009 Andrea Núñez Argote, World.
OPTIONS AND REQUIREMENTS FOR ENGAGEMENT OF CIVIL SOCIETY IN GEF PROJECTS presented by Ermath Harrington GEF Regional Focal Point.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Complex Needs and Challenging Behaviors – Of Service Providers Nicole Wiggins CAHMA Manager.
THE ROLE OF CONSUMERS IN TREATMENTS ADVOCACY Annie Madden, Executive Officer Australian Injecting & Illicit Drug Users League (AIVL)
Regional Videoconference Addressing Stigma and Discrimination of HIV/AIDS in Africa Thursday, April 2, 2009 UNAIDS Perspective Susan Timberlake, Senior.
PRESENTED AT THE STAKEHOLDERS FORUM ON QUALITY OF SERVICE AND CONSUMER EXPERIENCE LAICO REGENCY HOTEL Creating Space for Consumer Rights in.
The Australian Government’s Overseas Aid Program © Commonwealth of Australia 2003 Australia’s International Development Strategy for HIV Intensifying the.
The Role of PLWHA in Universal Access to Care and Treatment by 2010 Presented by Christopher Dorsett Chair, CRN+
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
European Public Health Alliance Advocating for Better Health in the EU Lara Garrido-Herrero (ANME General Assembly) Frankfurt, 11 November 2006.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
MODULE 3 Harm reduction advocacy
An example of a partnership is the Commonwealth Health Professions Alliance of which the CNF is a founding member. The CHPA is an alliance of Commonwealth.
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Sustainable Community Based Rehabilitation at local and national levels Presented by Professor Gwynnyth Llewellyn (University of Sydney) and Darryl Barrett.
Civil Society Consultation Frika Chia Iskandar
Principles Of Women Empowerment
Funding stigma reduction for key populations: innovation and actions
Needle and syringe exchange and working with injecting drug users
Harm reduction: decriminalising drug use in Asia
1. PAPUA NEW GUINEA FRIENDS FRANGIPANI
Community Action on Harm Reduction (CAHR) Programme
On behalf of GNP+ and PLHIV partner organisations
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Showing throughout the event
Biomedical Prevention Is Always About Social Justice, Too
‘ Children as Agents of Social Change  Opening Seminar
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 30 March 2011 Slide 1 A brief introduction.
Presentation transcript:

UN DPI/NGO CONFERENCE “DRUG INJECTION & HIV/AIDS: WHAT NEEDS TO BE DONE TO REACH GOAL 6?”

Overview  Involvement of civil society  Who is AIVL?  Drug User Networks globally  Nothing about us without us – why is involving people who inject drugs so important?  Reaching MDG 6 in relation to injecting drug use

Involving Civil Society  “Civil society” – within the context of the UN has generally come to mean:  Non-government, not-for-profit and community- based organisations;  Structures outside of government that form the basis of well-functioning societies;  Providing a ‘voice’ for communities;  Often represents the interests of individuals and groups that would otherwise not be heard;  Frequently involves large coalitions of groups and organisations with collective interests such as tackling HIV.

Involving Civil Society  Major international organisations and institutions including UN agencies now recognise the critical importance of civil society engagement.  Research evidence shows that empowering civil society improves the effectiveness and sustainability of programs and responses.  Acknowledged that the effectiveness of HIV prevention activities is critically dependent on the existence of diverse and sufficiently well resourced community based organisations.

Involving Civil Society In every country with a successful response to HIV/AIDS, civil society – in the form of community based organisations – have:  mobilised marginalized communities;  designed and implemented HIV prevention programs;  been instrumental in holding inactive governments to account;  influenced national prevention plans so that they meet the needs of the most affected communities. International HIV/AIDS Alliance, 2004.

Involving Civil Society  Governments and societies now familiar with the concept of ‘civil society’ through a highly diverse range of community-based organisations in many areas of life BUT...  What about in relation to people who inject drugs?  What does ‘civil society’ mean in relation to responding to injecting drug use and HIV?  Can people who inject drugs represent themselves?

Who is AIVL?  Australian Injecting and Illicit Drug Users League (AIVL)  Who/what is AIVL?  Peer-based organisation – run by and for people with a history of illicit drug use - primarily injecting drug use.  National peak organisation representing local drug user organisations in Australia and issues for drug users at the national level.

Who is AIVL?  AIVL has been in existence for 20 years - first 10 years without ongoing funding support.  In 2010 AIVL is a well-regarded organisation both in Australia and internationally.  AIVL has consistently demonstrated that drug users can run highly effective, transparent and accountable organisations.  AIVL represents a unique and critical perspective to government, the community, media, health services,etc.  Educate, advocate, represent and empower.

Drug User Networks globally  International  INPUD – International Network of People who Use Drugs  Regional  ANPUD – Asian Network of People who Use Drugs  National  Indonesia, Nepal, France, Germany, Thailand, Denmark...

“Nothing about us without us”  As an international network our main goal is the “meaningful involvement of people who use drugs” – MIPUD  Why “MIPUD”?  We have unique expertise and experiences and have a VITAL ROLE to play in responding to the health, social, legal and research policies that affect us.  We have the right to MEANINGFULLY PARTICIPATE in decision making on issues affecting us.

“Nothing about us without us”  Why should we care about “MIPUD”?  People who use drugs are not faceless, nameless people.  We are not just “collateral damage” from the war on drugs – we are people.  We are part of communities all over the world.  We have contributions to make to those communities if we are allowed to make them.  We are people who other people care about.  We are your sons, daughters, fathers, mothers, brothers and sisters.  For all of these reasons we should care more about how people who use drugs are treated.

Why is MIPUD important?  People who use drugs are among the most vilified and demonized groups in society.  We have been hit hard by the epidemics of HIV and hepatitis C.  We are regularly excluded from the decisions that affect our lives.

Why is MIPUD important?  We suffer oppression and human rights abuses in countries waging a “war against drugs” which too often turns into a war against people who use drugs.  We are often sent to prison or to compulsory detoxification and rehabilitation, instead of having access to the evidence-based treatment programmes we need.

Reaching Goal 6: HIV & IDU  So how do we reach MDG Goal 6 of effective HIV prevention and universal access to HIV treatment for all who need it by this year!  Resource and support the meaningful involvement of people who use drugs in responses;  Address the overwhelmingly negative impact of stigma, discrimination and criminalisation on people who use drugs;  Greatly improve access to evidence-based programs such as NSP and OST (methadone & buprenorphine); and  Support peer education among and by people who use drugs so we know how to protect ourselves.

Reaching Goal 6: HIV & IDU  The ‘violence’ against people who use drugs must stop before we can effectively address HIV or increase access to HIV treatment.  Need to remove the barriers to access.  Need to ‘harmonise’ drug control policies with public health outcomes.  Need to ensure people who use drugs are treated as human beings with basic dignity, respect and compassion.  And why should we do this. Why should we care?

Because in some countries compulsory prison-style camps are passed off as “drug treatment”... Because in many countries people are being humiliated and brutalised in the name of drug control... And because in some countries people are being tortured in the name of “health” and HIV prevention.

THANK YOU Annie Madden AIVL Executive Officer